Top 50 Emerging Leaders 2021 continued (in alphabetical order by CVC unit): Brian Walsh, head, Wind Ventures
Month: January 2021
Bolt Biotherapeutics charges to IPO stage
Novo and Pfizer are among the investors set to exit the cancer therapy developer, which has set a $100m target for its initial public offering.
Aledade aligns with corporates to raise $100m
GV-backed Aledade has secured series D funding at a $2.2bn post-money valuation to build out the business model for its primary care network.
Wattpad navigates to Naver in $600m acquisition
Bennett Coleman & Co, Globe Telecom and Tencent are set to exit the story sharing community operator in a cash-and-stock acquisition transaction by Naver.
Terns tracks $100m in IPO
Lilly Asia Ventures is the largest shareholder of liver disease therapy developer Terns, which closed a $97.7m round earlier this month.
Quali counts up $54m
The Dell and Orr Partners-backed cloud software developer has collected $54m in a round co-led by Greenfield Partners and Jerusalem Venture Partners.
Blue Horizon blows fund up to $220m
Givaudan and Grupo Bimbo are among the limited partners in foodtech investor Blue Horizon Ventures’ debut venture fund.
Groove X tunes into $26m series B3 round
Hitachi Global Life Solutions, Sompo and NTT Docomo provided the cash for the creator of a family companion robot called Lovot, taking its total funding to $128m.
Amazon unveils Indian accelerator partnership
The corporate launched Amazon Global Selling Propel with venture capital firms and a government-backed scheme to support emerging India-based consumer brands.
Lovys lands series A funding
Maif Avenir has backed a $20.6m round for the digital insurance provider, which has now raised approximately $26m altogether.
Rivian trucks in $2.65bn
Amazon returned for a round valuing the electric truck developer at $27.6bn as it prepares to release its first vehicles later this year.
PPRO progresses with $180m
The PayPal and Citi-backed cross-border payment technology provider has raised new funding at a valuation topping $1bn.
Globality gulps down $138m in series E
SoftBank Vision Fund returned to reinvest in the outsourcing marketplace operator at a valuation of almost $1bn to take its total funding to $310m.
Vor Biopharma goes for $150m in IPO
PureTech Health, Johnson & Johnson and Novartis are in line for exits after the cancer drug developer filed for its initial public offering.